TVRD•benzinga•
Jones Trading Initiates Coverage On Tvardi Therapeutics with Buy Rating, Announces Price Target of $39
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 28, 2025 by benzinga